Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2024Epidemiology and Vaccinal PreventionOpen Access

Vaccination against Measles in Patients with Oncological Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SKS. M. KharitIFI. V. FridmanАРА. А. Рулева

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kharit et al. (2024) studied this question.

synapsesocial.com/papers/68e6bbccb6db64358763c229https://doi.org/10.31631/2073-3046-2024-23-2-71-77
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1[Evaluation of changes in serum measles antibody levels in children with tumors before and after chemotherapy and the necessity of revaccination with measles-containing vaccines].2025
  2. 2Seroprevalence of measles antibodies in children with cancer: results of a 2024 UK service evaluation2025
  3. 3Assessment of Immunization Status Following Non-HSCT Chemotherapy-treated Pediatric Leukemia Survivors2026
  4. 4Seroprevalence of Measles (Rubeola) Antibodies in Childhood Cancer Survivors2024 · 1 citations
  5. 5Vaccine-Induced Immunity in Children and Adolescents After Chemotherapy for Acute Lymphoblastic Leukemia: A Systematic Review2026